SG11201707926WA - Streptococcal vaccine - Google Patents
Streptococcal vaccineInfo
- Publication number
- SG11201707926WA SG11201707926WA SG11201707926WA SG11201707926WA SG11201707926WA SG 11201707926W A SG11201707926W A SG 11201707926WA SG 11201707926W A SG11201707926W A SG 11201707926WA SG 11201707926W A SG11201707926W A SG 11201707926WA SG 11201707926W A SG11201707926W A SG 11201707926WA
- Authority
- SG
- Singapore
- Prior art keywords
- streptococcal vaccine
- streptococcal
- vaccine
- Prior art date
Links
- 229940124840 Streptococcal vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2015901098A AU2015901098A0 (en) | 2015-03-26 | Streptococcal vaccine | |
PCT/AU2016/050231 WO2016149771A1 (en) | 2015-03-26 | 2016-03-24 | Streptococcal vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201707926WA true SG11201707926WA (en) | 2017-10-30 |
Family
ID=56976886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201707926WA SG11201707926WA (en) | 2015-03-26 | 2016-03-24 | Streptococcal vaccine |
Country Status (12)
Country | Link |
---|---|
US (2) | US10821168B2 (en) |
EP (1) | EP3273989B1 (en) |
JP (2) | JP6903046B2 (en) |
KR (1) | KR20170129786A (en) |
CN (2) | CN107427569B (en) |
AU (1) | AU2016236770B2 (en) |
BR (1) | BR112017020178A2 (en) |
CA (1) | CA2980616A1 (en) |
ES (1) | ES2970824T3 (en) |
MY (1) | MY191539A (en) |
SG (1) | SG11201707926WA (en) |
WO (1) | WO2016149771A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016236770B2 (en) | 2015-03-26 | 2022-03-10 | Gpn Vaccines Pty Ltd | Streptococcal vaccine |
EP3387006A4 (en) * | 2015-12-10 | 2019-05-08 | National Research Council of Canada | Lipidatedstreptococcus pneumoniae |
JP7164200B2 (en) | 2016-03-31 | 2022-11-01 | ポゴナ, エルエルシー | Compositions of Saccharide-Polypeptide Conjugates and Methods of Their Use |
US20200330579A1 (en) * | 2017-10-04 | 2020-10-22 | Liffey Biotech Limited | Saccharide-polypeptide conjugate compositions and methods of use thereof |
WO2020145426A1 (en) * | 2019-01-08 | 2020-07-16 | 한국원자력연구원 | Method for preparing live attenuated vaccine by radiation and live attenuated vaccine composition prepared thereby |
KR20200097134A (en) * | 2019-02-07 | 2020-08-18 | 에스케이바이오사이언스(주) | Pneumococcal antiserum with out cross-reactivity and method for producing the same |
US20210361757A1 (en) * | 2020-05-22 | 2021-11-25 | GPN Vaccines Ltd | Streptococcal vaccine formulations and uses thereof |
US20210361758A1 (en) * | 2020-05-22 | 2021-11-25 | GPN Vaccines Ltd | Streptococcal vaccines and methods for use |
CN113005072A (en) * | 2021-04-09 | 2021-06-22 | 佛山科学技术学院 | Streptococcus equi subsp zooepidemicus gene deletion strain and preparation method and application thereof |
CN117159480B (en) * | 2023-11-01 | 2024-03-01 | 江西赛基生物技术有限公司 | Recombinant human IFN-gamma protein freeze-dried pellet and preparation method and application thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3567938A (en) | 1968-02-14 | 1971-03-02 | Credo Inc | Gamma ray laser |
US3557370A (en) | 1968-02-14 | 1971-01-19 | Dawson Inc Alexander | Gamma ray laser having a low temperature closed resonating cavity |
WO1990013285A1 (en) | 1989-05-01 | 1990-11-15 | Enzytech, Inc. | Process for producing small particles of biologically active molecules |
CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
ATE188613T1 (en) | 1992-06-25 | 2000-01-15 | Smithkline Beecham Biolog | VACCINE COMPOSITION CONTAINING ADJUVANTS |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
ATE420171T1 (en) | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | IMMUNOMODULATORY OLIGONUCLEOTIDES |
UA56132C2 (en) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Vaccine composition (variants), method for stabilizing qs21 providing resistance against hydrolysis (variants), method for manufacturing vaccine |
AT408615B (en) | 1998-09-15 | 2002-01-25 | Immuno Ag | NEW INFLUENCE VIRUS VACCINE COMPOSITION |
GB9906437D0 (en) * | 1999-03-19 | 1999-05-12 | Smithkline Beecham Biolog | Vaccine |
GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
AU2004294732B2 (en) * | 2003-12-03 | 2009-10-08 | Intervet International B.V. | Streptococcus phocae vaccine |
AR054822A1 (en) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | ADMISSION IMMUNE EMULSION |
CA2808919C (en) * | 2005-12-22 | 2016-04-19 | Glaxosmithkline Biologicals S.A. | Streptococcus pneumoniae capsular saccharide vaccine |
KR20110009157A (en) * | 2008-04-16 | 2011-01-27 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Vaccine |
WO2012100302A1 (en) * | 2011-01-27 | 2012-08-02 | Gamma Vaccines Pty Limited | Combination vaccines |
EA201391553A1 (en) | 2011-04-20 | 2014-03-31 | Майко Байо, Инк. | COMPOSITION AND METHOD OF STRENGTHENING IMMUNE RESPONSE |
CA2902560A1 (en) * | 2013-03-14 | 2014-09-25 | President And Fellows Of Harvard College | Nanoparticle-based compositions |
AU2016236770B2 (en) * | 2015-03-26 | 2022-03-10 | Gpn Vaccines Pty Ltd | Streptococcal vaccine |
-
2016
- 2016-03-24 AU AU2016236770A patent/AU2016236770B2/en active Active
- 2016-03-24 KR KR1020177027087A patent/KR20170129786A/en active IP Right Grant
- 2016-03-24 MY MYPI2017001386A patent/MY191539A/en unknown
- 2016-03-24 EP EP16767548.7A patent/EP3273989B1/en active Active
- 2016-03-24 WO PCT/AU2016/050231 patent/WO2016149771A1/en active Application Filing
- 2016-03-24 JP JP2018500828A patent/JP6903046B2/en active Active
- 2016-03-24 ES ES16767548T patent/ES2970824T3/en active Active
- 2016-03-24 SG SG11201707926WA patent/SG11201707926WA/en unknown
- 2016-03-24 CN CN201680018751.3A patent/CN107427569B/en active Active
- 2016-03-24 CN CN202211670283.1A patent/CN116603058A/en active Pending
- 2016-03-24 US US15/561,910 patent/US10821168B2/en active Active
- 2016-03-24 CA CA2980616A patent/CA2980616A1/en active Pending
- 2016-03-24 BR BR112017020178A patent/BR112017020178A2/en active Search and Examination
-
2020
- 2020-08-24 US US17/001,474 patent/US11235048B2/en active Active
-
2021
- 2021-06-21 JP JP2021102504A patent/JP7269281B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3273989A4 (en) | 2018-08-08 |
EP3273989A1 (en) | 2018-01-31 |
JP2021138781A (en) | 2021-09-16 |
JP7269281B2 (en) | 2023-05-08 |
US20210170011A1 (en) | 2021-06-10 |
WO2016149771A1 (en) | 2016-09-29 |
CN116603058A (en) | 2023-08-18 |
AU2016236770B2 (en) | 2022-03-10 |
EP3273989C0 (en) | 2023-12-27 |
KR20170129786A (en) | 2017-11-27 |
BR112017020178A2 (en) | 2018-06-12 |
MY191539A (en) | 2022-06-30 |
US10821168B2 (en) | 2020-11-03 |
ES2970824T3 (en) | 2024-05-30 |
US11235048B2 (en) | 2022-02-01 |
EP3273989B1 (en) | 2023-12-27 |
CA2980616A1 (en) | 2016-09-29 |
US20180117136A1 (en) | 2018-05-03 |
AU2016236770A1 (en) | 2017-10-12 |
CN107427569B (en) | 2022-12-30 |
CN107427569A (en) | 2017-12-01 |
JP6903046B2 (en) | 2021-07-14 |
JP2018513877A (en) | 2018-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201518684D0 (en) | Vaccine | |
GB201410971D0 (en) | Vaccine | |
PL3185899T3 (en) | Improved hvt-vectored nd-ibd vaccine | |
SG11201707926WA (en) | Streptococcal vaccine | |
ZA201607355B (en) | Group a streptococcus vaccine | |
GB201522132D0 (en) | Vaccine | |
GB201616904D0 (en) | Vaccine | |
HUE053256T2 (en) | Sequence variants | |
GB201415602D0 (en) | Streptococcal antigens | |
GB201608821D0 (en) | Vaccines | |
PL3188755T3 (en) | Vaccine | |
GB201402083D0 (en) | Retaining means | |
GB201417214D0 (en) | Vaccine | |
SI3193923T1 (en) | Adjuvants | |
GB201504579D0 (en) | Ovine vaccine | |
GB2522661B (en) | Context configuration | |
GB201712904D0 (en) | Vaccine | |
GB201707785D0 (en) | Vaccination | |
GB201706798D0 (en) | Vaccination | |
GB201704126D0 (en) | Vaccine | |
GB201703809D0 (en) | Vaccine | |
GB201614387D0 (en) | Improved vaccines | |
GB201603029D0 (en) | Vaccine | |
GB201518917D0 (en) | Vaccination | |
AU2015901098A0 (en) | Streptococcal vaccine |